FEAF
TPEx

3491 昇達科

1,430.00 ▼ 25.00 (1.72%) Close · 2026-11-13 · TPEx
Ask about 3491
This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.

Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.

Your risk profile
Conclusion

Mixed picture: 2 strengths against 1 watch-outs. Weigh them against your own goals.

For a moderate profile, none of the items above crosses the watch-out thresholds set by the team.

No model narrative: the model call failed. The structured analysis above is complete on its own.

Strengths

+ Return on equity 21.9% with a 28.6% net margin: highly profitable. source (Key Stats) →
+ Liabilities are only 39.5% of total assets (Q3 2026): a light debt load. source (Financials) →

Watch-outs

! Free cash flow was negative in 2025: -64 NT$ million, so spending exceeded operating cash. source (Financials) →

What to check before deciding

?What is the spending for, and when does it start paying back?

What the analysis found

· Growth Revenue grew modestly, 5.0% in 2025; latest quarter Q3 2026: 74.2% year on year. source →
+ Profitability Return on equity 21.9% with a 28.6% net margin: highly profitable. source →
+ Debt Liabilities are only 39.5% of total assets (Q3 2026): a light debt load. source →
! Cash flow Free cash flow was negative in 2025: -64 NT$ million, so spending exceeded operating cash. source →
· Filings 2 verified alert(s); latest on 2026-11-11: 公告本公司董事會決議發行國內第四次無擔保轉換公司債 source →
· Filings 2 filing(s) are held or rejected and wait for human review. source →